Ibiayi Dagogo-Jack, MD

home / authors / ibiayi-dagogo-jack-md

Articles

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the next steps for biomarker testing in NSCLC.

How Biomarker Testing Could Continue to Evolve in NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 11th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the next steps for biomarker testing in NSCLC.

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on tissue and liquid biopsies for biomarker testing in NSCLC.

Tissue vs Liquid Biopsies for Biomarker Testing in NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 11th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on tissue and liquid biopsies for biomarker testing in NSCLC.

Benefits of In-House Biomarker Testing in NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 11th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the benefits of in-house biomarker testing in NSCLC.

Treatment Planning After Biomarker Testing in NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 11th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on treatment planning after biomarker testing in NSCLC.

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the sensitivity and specificity of Rapid Lung NGS for biomarker testing in NSCLC.

The Specificity/Sensitivity of Rapid Lung NGS for Biomarker Testing in NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 11th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the sensitivity and specificity of Rapid Lung NGS for biomarker testing in NSCLC.

The Utility of Rapid Lung NGS for Biomarker Testing in NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 11th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the utility of Rapid Lung NGS for biomarker testing in NSCLC.

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on when to conduct biomarker testing in NSCLC.

When to Conduct Molecular Testing in NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 11th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on when to conduct biomarker testing in NSCLC.

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on biomarker testing in metastatic or resectable non–small cell lung cancer.

The Role of Biomarker Testing in Metastatic and Resectable NSCLC

Jessica Donington, MD, MSCR;Melina Elpi Marmarelis, MD;Ibiayi Dagogo-Jack, MD

November 8th 2024

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on biomarker testing in metastatic or resectable non–small cell lung cancer.